Oligonucleotide Synthesis Market
The global oligonucleotide synthesis market is growing at a significant rate, due to the
mounting usage of synthesized oligonucleotides in molecular diagnostics and clinical
applications, and intensifying demand for synthesized oligonucleotides.
Different products such as a reagent, synthesized oligonucleotides, and equipment
contributed to the oligonucleotide synthesis market size. The market has witnessed high
demand synthesized oligonucleotides due to its escalating number of applications of in
diagnostics, research, and therapeutics.
By Product: The synthesised oligonucleotides segment accounted for the largest share of all
products and is projected to grow at the fastest pace on the market due to its rising number
of applications in diagnostics, research and therapeutics.
By Application: The application of diagnostics is expected to develop at the fastest pace
among all applications in the market for oligonucleotide synthesis, owing to the rapid
evolution in the field of molecular diagnostics.
By End User: Diagnostic laboratories are expected to develop at the fastest pace of all end
users in the market for oligonucleotide synthesis, due to the growing diagnostic applications
of oligonucleotides and the evolving field of molecular diagnostics.
The key growth factors for the oligonucleotide synthesis market are the growing use of
synthesised oligonucleotides in molecular diagnostics and clinical applications, the increase
in venture capital activities, the increasing prevalence of cancer and infectious diseases, the
increasing demand for synthesised oligonucleotides, and increasing government spending.
In February 2019, an arrangement with BioNTech was entered into by Thermo Fisher
Science (Germany). Under the terms of this arrangement, Thermo Fisher will support the
messenger RNA (mRNA) development platform of BioNTech via the procurement of
nucleotides, enzymes, and other essential raw materials.
In March 2018, Danaher pur